About this trial
The purpose of this randomized, controlled trial is to investigate whether coronary computed tomography (CT) angiography prior to catheter ablation and derived treatment (medical anti-ischemic and multimodality treatment and/or mechanical revascularization) can improve clinical outcomes in patients with atrial fibrillation undergoing catheter ablation.
A sub-study will investigate the effect of different ablation strategies on clinical outcomes in patients with atrial fibrillation undergoing catheter ablation.
Eligibility criteria
Qualifiers
Age over 18 years.
Referral for catheter ablation treatment (excluding AV-junction ablation) for atrial fibrillation (both paroxysmal and persistent atrial fibrillation) at the Department of Cardiology at Gentofte Hospital. Both first ablation and re-ablation treatments are included.
The ability and willingness to provide written informed consent.
Disqualifiers
Known atherosclerotic cardiovascular disease (ASCVD).
Ongoing treatment with statins.
Contraindications for coronary CT angiography, e.g. contrast allergy
Recent coronary CT angiography including CAC-score without positive findings <3 years prior to screening.
Trial design
Treatments tested in this trial
- Analysis of coronary CT Angiography and CAC scoring at the time of catheter ablation
Treatment groups
Sponsors and collaborators
Tor Biering-Sørensen
Lead sponsor
Herlev and Gentofte Hospital
Sponsor institution